8-KFinancial Events

EIDP, Inc. 8-K Report, Financial Obligation (Mar 26, 2013)

Filed March 26, 2013For Securities:CTA-PBCTA-PA

Summary

This 8-K filing details significant technology license agreements entered into by DuPont, through its subsidiary Pioneer Hi-Bred International, Inc., with Monsanto Company. The agreements grant DuPont access to key herbicide tolerance traits (Roundup Ready 2 Yield® and dicamba tolerance) for soybeans in the U.S. and Canada, as well as access to important regulatory data and maintenance support for existing traits in corn and soybeans. These licenses are crucial for DuPont's agricultural products, particularly in enhancing its soybean offerings with advanced herbicide resistance capabilities. While these agreements provide valuable technological assets, they also introduce substantial financial obligations for DuPont. The company is committed to significant upfront and variable royalty payments, with a notable commitment of $802 million in fixed annual royalty payments between 2014 and 2017. Furthermore, from 2018 onwards, DuPont will incur per-unit royalties with minimum annual payments totaling $950 million through 2023. Additionally, these agreements resolve ongoing litigation between the two companies, including the dismissal of Monsanto's willful infringement claim and DuPont's antitrust counterclaims, though a "fraud" sanction against DuPont remains open for immediate appeal.

Key Highlights

  • 1DuPont (via Pioneer) secured non-exclusive licenses from Monsanto for Genuity® Roundup Ready 2 Yield® glyphosate tolerance and dicamba tolerance traits for use in soybean seeds in the U.S. and Canada.
  • 2The agreements also include access to post-patent regulatory data and maintenance support for existing Roundup Ready® and YieldGard® traits in corn and soybeans.
  • 3DuPont is obligated to make significant royalty payments, with fixed annual payments of $802 million between 2014-2017.
  • 4From 2018, DuPont will pay per-unit royalties with annual minimums totaling $950 million through 2023 for the licensed traits.
  • 5The agreements resolve Monsanto's claim of willful patent infringement against DuPont, including a past jury award.
  • 6DuPont's antitrust counterclaims against Monsanto will be dismissed as part of the settlement.
  • 7A "fraud" sanction against DuPont is slated for immediate appeal, indicating ongoing legal complexities despite the license agreement.

Frequently Asked Questions

DuPont faces substantial financial commitments, including $802 million in fixed annual royalty payments from 2014 to 2017, and a minimum of $950 million in total annual minimum payments from 2018 through 2023, in addition to per-unit royalties. The total contemplated payment for trait technology, data, and soybean lines is $1,752 million.

These licenses significantly enhance DuPont's agricultural portfolio by incorporating advanced herbicide tolerance traits (Roundup Ready 2 Yield® and dicamba tolerance) into their soybean seeds. They also provide crucial access to regulatory data for existing traits, supporting the continued commercialization of their corn and soybean varieties.

The agreements resolve Monsanto's claim of willful infringement of its Roundup Ready® 1 soybean patent, including a previously awarded jury damage amount. DuPont's antitrust counterclaims against Monsanto are also dismissed. However, a "fraud" sanction against DuPont is still subject to an immediate appeal.

No, the license for Monsanto's Genuity® Roundup Ready 2 Yield® glyphosate tolerance trait and dicamba tolerance trait is non-exclusive.